2.4 Cellular Phases of Burn Wound Healing and Scar Pathobiology

2.4 Cellular Phases of Burn Wound Healing and Scar Pathobiology

Core Principle: Cutaneous burn wound healing is an intricate, dynamic biological process designed to restore the barrier integrity of the skin. Unlike clean incisional surgical wounds, thermal burn wounds involve a massive zone of non-viable coagulated protein (eschar), persistent ischemia, and prolonged inflammatory signaling. Understanding the cellular transitions between hemostasis, inflammation, proliferation, and remodeling is vital to predicting pathological fibrogenesis, hypertrophic scar formation, and the necessity for early surgical excision.

---

1. The Four Overlapping Cellular Phases of Wound Healing

Relative Cellular
Activity / Biomass
    ▲
    │ ┌──────────────┐
    │ │ 1. Hemostasis│ ┌────────────────┐
    │ └──────┬───────┘ │ 2. Inflammation│ ┌─────────────────┐
    │        │         └───────┬────────┘ │ 3. Proliferation │ ┌──────────────────┐
MAX │        │                 │          └────────┬────────┘ │  4. Remodeling &  │
    │        ▼                 ▼                   ▼          │    Maturation     │
    │     Platelets       Neutrophils         Fibroblasts     └────────┬──────────┘
    │      Fibrin         Macrophages         Angiogenesis             ▼
    │      PDGF           Phagocytosis        Type III Collagen   Type I Collagen
    │                     M1 -> M2 Shift      Epithelialization   Myofibroblasts (α-SMA)
MIN │                                                             Tensile Strength -> 80%
    └───┴───────────────┴─────────────────┴───────────────────┴───────────────────────►
       0 hrs           Day 1-4             Day 4-21            Day 21 to 1-2 Years

Phase 1: Hemostasis (Minutes to Hours Post-Injury)

• Vascular Event: Immediate transient microvascular vasoconstriction (mediated by endothelin-1, thromboxane A2, and sympathetic discharge) lasting 5–10 minutes to limit immediate hemorrhage.
• Cellular & Molecular Cascade: Platelets adhere to exposed subendothelial collagen via von Willebrand factor (vWF) and glycoprotein Ib/IIb/IIIa receptors. Platelet degranulation releases:
  • Platelet-Derived Growth Factor (PDGF): Potent chemoattractant for neutrophils and fibroblasts.
  • Transforming Growth Factor-beta (TGF-β): Initiates the fibrogenic and inflammatory signaling cascades.
  • Epidermal Growth Factor (EGF): Stimulates subsequent keratinocyte proliferation.
• Provisional Matrix: Thrombin cleaves fibrinogen into fibrin, creating a three-dimensional fibrin-fibronectin scaffold that anchors infiltrating inflammatory cells.

Phase 2: Inflammatory Phase (Days 1 to 4)

• Neutrophil Influx (First 24–48 Hours): Driven by IL-8, leukotriene B4 (LTB4), and complement fragment C5a. Neutrophils phagocytose bacteria, necrotic debris, and denatured protein. They release reactive oxygen species (ROS) and matrix metalloproteinases (MMPs, such as MMP-8/neutrophil collagenase).
• Macrophage Transition (Days 2 to 5): Monocytes marginate and differentiate into tissue macrophages. Macrophages serve as the essential orchestrators of wound repair:
  • M1 Macrophages (Pro-inflammatory): Clear cellular debris and sustain antimicrobial defenses.
  • M2 Macrophages (Pro-reparative): Secrete growth factors that drive the transition into the proliferative phase: Vascular Endothelial Growth Factor (VEGF), basic Fibroblast Growth Factor (bFGF), and TGF-β1.

Phase 3: Proliferative Phase (Days 4 to 21)

• Fibroplasia & Provisional Matrix: Dermal fibroblasts migrate along the fibrin scaffold, proliferate, and synthesize abundant extracellular matrix (ECM) rich in Type III collagen, hyaluronic acid, and proteoglycans.
• Angiogenesis (Granulation Tissue): Endothelial cells respond to VEGF and bFGF by forming capillary buds (neovascularization), creating beefy-red, highly vascular, and fragile granulation tissue.
• Re-epithelialization: Keratinocytes at the wound edges and from preserved dermal appendages (hair follicles, sebaceous glands, and eccrine sweat ducts) undergo phenotypic alteration, dissolve hemidesmosomal attachments, and migrate across the provisional matrix (leap-frog and train-movement models) until contact inhibition halts migration.

Phase 4: Remodeling and Maturation Phase (Day 21 to 1–2 Years)

• Collagen Isotype Transition: Matrix metalloproteinases (MMPs) systematically degrade loose, fragile Type III collagen, which is replaced by dense, mature Type I collagen organized into thick, parallel bundles oriented along lines of mechanical tension.
• Normal Skin Collagen Ratio: Normal unburned dermis has a Type I to Type III collagen ratio of approximately 4:1 (80% Type I, 20% Type III).
• Wound Contraction: A subset of fibroblasts differentiates into myofibroblasts, expressing alpha-smooth muscle actin (α-SMA) within their cytoskeleton. Myofibroblasts anchor to surrounding matrix fibrils and contract, pulling wound edges inward.
• Tensile Strength Plateau: Wound tensile strength increases progressively over months:
  • 3 Weeks: ~20% of normal.
  • 6 Weeks: ~50% of normal.
  • Maximum Plateau (1–2 Years): 70% to 80% of unwounded skin strength. Burn scar tissue never recovers 100% of the tensile strength or elasticity of native intact skin because elastin fibers fail to regenerate normally.

---

2. Pathobiology of Abnormal Burn Scarring: Hypertrophic Scars vs. Keloids

Abnormal, fibroproliferative scarring represents one of the most debilitating long-term consequences of thermal injury, resulting in severe physical contractures, chronic pain, neuropathic pruritus, and disfigurement.

HYPERTROPHIC SCAR (Common in Burns):            KELOID SCAR (Rare in Pure Burns): 
                                                 Extends far beyond original boundary
        Confined to original burn borders       ┌─────────────────────────────────────┐
            ┌───────────────────────┐           │                                     │
────────────┘                       └───────────┴─ ── ── ── ── ── ── ── ── ── ── ── ──┴────────────
Native Skin      Elevated, erythematous,        Native Skin      Tumor-like, claw-like invasion
                 rigid whorls of collagen                        of adjacent normal dermis

---

3. The "21-Day Rule" and the Molecular Drivers of Fibrosis

The fundamental clinical guideline governing burn wound surgical management is the 21-Day Rule:

Wound Healing Time vs. Hypertrophic Scar Risk:
  • Healed in < 14 Days (Superficial partial-thickness): < 10-15% risk of hypertrophic scarring.
  • Healed in 14 - 21 Days (Mid partial-thickness): 20 - 35% risk of hypertrophic scarring.
  • Healing Requires > 21 Days (Deep partial-thickness): > 70 - 85% risk of severe hypertrophic scarring.

┌─────────────────────────────────────────────────────────────┐
│         Prolonged Open Wound & Inflammation (>21 Days)      │
└──────────────────────────────┬──────────────────────────────┘
                               │
                               ▼
┌─────────────────────────────────────────────────────────────┐
│ Sustained Macrophage Activation & Mast Cell Degranulation   │
│         Massive Overexpression of TGF-β1 and TGF-β2         │
└──────────────────────────────┬──────────────────────────────┘
                               │
        ┌──────────────────────┴──────────────────────┐
        ▼                                             ▼
┌──────────────────────────────┐            ┌──────────────────────────────┐
│ Myofibroblast Persistence    │            │ Extracellular Matrix (ECM)   │
├──────────────────────────────┤            ├──────────────────────────────┤
│ • Failure of programmed cell │            │ • Uncontrolled Type III      │
│   death (apoptosis)          │            │   collagen deposition        │
│ • Continuous α-SMA-mediated  │            │ • Downregulation of MMPs /   │
│   mechanical contraction     │            │   Upregulation of TIMPs      │
│ • Joint & skin contractures  │            │ • Rigid, inelastic scar mass │
└──────────────────────────────┘            └──────────────────────────────┘

Molecular Signaling Mechanisms in Hypertrophic Scarring:

1. TGF-β Isoform Dysregulation:
   • TGF-β1 and TGF-β2: Potent pro-fibrotic cytokines that stimulate fibroblast proliferation, upregulate collagen gene transcription, and induce myofibroblast differentiation.
   • TGF-β3: Anti-fibrotic cytokine that promotes scarless fetal-like wound healing. In hypertrophic scars, the ratio of $(TGF-\beta1 + TGF-\beta2) : TGF-\beta3$ is drastically elevated.
2. Myofibroblast Apoptosis Resistance: In normal wound healing, myofibroblasts undergo programmed cell death (apoptosis) once the wound is re-epithelialized. In hypertrophic scars, prolonged inflammatory signaling prevents apoptosis, allowing myofibroblasts to perpetually secrete collagen and contract tissue for years.
3. MMP / TIMP Imbalance: Matrix metalloproteinases (which break down collagen) are suppressed by excessive tissue inhibitors of metalloproteinases (TIMPs), leading to net accumulation of rigid, disorganized collagen whorls.
4. Mast Cell & Histamine-Driven Pruritus: Chronic degranulation of mast cells within the active scar tissue releases histamine, substance P, and serotonin, creating severe, intractable neuropathic and inflammatory burn itch (pruritus).

---

4. Clinical Implications for Burn Nursing Practice

1. Advocacy for Early Excision & Grafting: Wounds identified as deep partial-thickness or full-thickness that will not heal spontaneously within 21 days should undergo early tangential excision and autografting (typically on post-injury days 2–5) to abort the chronic inflammatory cascade and prevent hypertrophic scar formation.
2. Early Implementation of Compression Therapy: Applying continuous, uniform pressure (20 to 30 mmHg) via custom elastic pressure garments starves the hyperactive scar of microvascular blood supply, induces local tissue hypoxia, accelerates myofibroblast apoptosis, and forces collagen bundles into parallel alignment.
3. Anti-Deformity Positioning: Because myofibroblasts exert continuous contractile forces, all joints must be positioned in anti-contracture alignment (e.g., neck extension, shoulder abduction at 90°, elbow and knee extension, ankle neutral at 90°) throughout the proliferative and remodeling phases.